Quercetin

Quercetin

SCHEMBL29353785

O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 1.00
KMT2A Q03164 11/20 1.00
CYP1A2 P05177 8/20 1.00
CYP3A4 P08684 8/20 1.00
KDM4E B2RXH2 8/20 1.00
HSD17B10 Q99714 8/20 1.00
MAPT P10636 8/20 1.00
CYP2C9 P11712 7/20 1.00
RECQL P46063 7/20 1.00
CYP1A1 P04798 7/20 1.00
CYP1B1 Q16678 7/20 1.00
XDH P47989 7/20 1.00
FTO Q9C0B1 7/20 1.00
ALOX15 P16050 6/20 1.00
ABCB1 P08183 6/20 1.00
APP P05067 6/20 1.00
POLH Q9Y253 6/20 1.00
POLB P06746 5/20 1.00
TP53 P04637 5/20 1.00
IPMK Q8NFU5 5/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quercetin SCHEMBL29723041 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL31507620 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL29351036 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL19723 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL17629824 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL118425 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL6756842 0.99 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL3786991 0.99 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL22103 0.99 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4KDM4E
Quercetin SCHEMBL21585504 0.99 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 622 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260007603-A1 ALPHA-KETOGLUTARATE (AKG)-BASED POLYMERIC MICROPARTICLES AND METHODS OF USE UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2026-01-08 US claimed
EP-3936608-B1 REPROGRAMMING CELLS SCRIPPS RESEARCH INST (US) 2025-05-07 EP claimed
CN-119909036-A Preparation method and application of iron death adjustment nanoparticle based on unsaturated fatty acid 郑州大学 2025-05-02 CN claimed
WO-2025049883-A1 COMPOSITIONS AND METHODS FOR TREATING A DISEASE OR DISORDER ASSOCIATED WITH SENESCENCE JLM EXOGRADE, LLC (US) 2025-03-06 WO claimed
CN-119243164-A Wax gourd leaf extract corrosion inhibitor, preparation method and application 重庆昆顶环保科技有限公司 2025-01-03 CN claimed
CN-119019999-A Electric automobile cooling liquid and preparation method thereof 上海德联化工有限公司 2024-11-26 CN claimed
EP-4326892-A1 METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA NAOS Institute of Life Science (FR) 2024-02-28 EP claimed
CN-117322621-A Preparation method of antibacterial emulsion containing soybean protein isolate hydrolysate, fructus Schisandrae polysaccharide and quercetin 东北农业大学 2024-01-02 CN claimed
US-20230354845-A1 HIGHLY CAFFEINATED COCOA-BASED COMPOSITION AND METHODS OF MAKING AND USING THEREOF SEATTLE GUMMY COMPANY (US) 2023-11-09 US claimed
US-20230321063-A1 COMPOSITIONS AND METHODS TO REDUCE NEUROINFLAMMATION SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) 2023-10-12 US claimed
EP-4081334-A1 HIGHLY PERMEABLE ULTRATHIN POLYMER NANOFILM COMPOSITE MEMBRANE AND A PROCESS FOR PREPARATION THEREOF Council of Scientific & Industrial Research (IN) 2022-11-02 EP claimed
WO-2022223928-A1 METHOD FOR SELECTING ECOBIOLOGICAL TOPICAL COMPOSITIONS AND INGREDIENTS CAPABLE OF RESTORING OR REINFORCING THE SKIN MICROBIOTA NAOS INSTITUTE OF LIFE SCIENCE (FR) 2022-10-27 WO claimed
US-20220339166-A1 POST COVID19 VACCINE REMEDIES IPRX, LLC 2022-10-27 US claimed
CN-114773580-A Irregular ternary conjugated polymer photocatalytic material and preparation method and application thereof 太原理工大学 2022-07-22 CN claimed
WO-2022148788-A1 SLOW-RELEASE DEVICE FOR WOUND DISINFECTION AND ITS USAGE JUSTUS-LIEBIG UNIVERSITÄT GIESSEN (DE) 2022-07-14 WO claimed
EP-4017585-A1 FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES Mühlbauer Technology GmbH (DE) 2022-06-29 EP claimed
CN-114522727-A Halogenated aromatic linear conjugated polymer photocatalytic material, and preparation method and application thereof 太原理工大学 2022-05-24 CN claimed
WO-2022065871-A1 LIGHT SOURCE MODULE FOR PLANT CULTIVATION AND LIGHT SOURCE DEVICE INCLUDING SAME FOR PLANT CULTIVATION 충북대학교 산학협력단 2022-03-31 WO claimed
WO-2022065914-A1 ANTICOCCIDIAL COMPOSITION COMPRISING GINKGO LEAVES AND USE THEREOF 씨제이제일제당 (주) 2022-03-31 WO claimed
WO-2022040606-A1 COMPOSITIONS AND METHODS TO REDUCE NEUROINFLAMMATION SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) 2022-02-24 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321063-A1 COMPOSITIONS AND METHODS TO REDUCE NEUROINFLAMMATION CXCR3, MTOR, CX3CR1 MEN1 2417/4885KMT2A 4011/4885CYP1A2 4815/4885
US-20260007603-A1 ALPHA-KETOGLUTARATE (AKG)-BASED POLYMERIC MICROPARTICLES AND METHODS OF USE PLOD1, OXGR1, PLOD2 MEN1 4844/4885KMT2A 692/4885CYP1A2 346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.